Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cardio Diagnostics Holdings
AddedFeb 20, 2024
UpdatedJun 18, 2026
Cardio Diagnostics Holdings

Cardio Diagnostics Holdings

Public

Chicago-based Cardio Diagnostics uses AI to enhance early detection and prevention of cardiovascular disease.

HQ
Chicago, IL, US
Founded
2017
Overview
Compare
Employees

Cardio Diagnostics Holdings, based in Chicago, Illinois, focuses on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company leverages its proprietary AI-driven Integrated Genetic-Epigenetic Engine to offer advanced medical technology solutions aimed at improving cardiovascular health outcomes.

Cardio Diagnostics has made significant strides in the biotechnology sector, becoming a leader in AI-driven cardiovascular disease management. Their innovative approach has garnered attention for its potential to transform how cardiovascular conditions are detected and treated, contributing to better patient outcomes.

Cardio Diagnostics Holdings - Similar Companies

Cardiodiagnostics logo

Cardiodiagnostics

HDL Diagnostics logo

HDL Diagnostics

Heartio logo

Heartio

heartio.ai

Arterial Health International logo

Arterial Health International

Cardiac Insight logo

Cardiac Insight

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

CDx Diagnostics logo

CDx Diagnostics

InVision Medical Technology logo

InVision Medical Technology

AngioInsight logo

AngioInsight

angioinsight.com

CardioOptics logo

CardioOptics

Cardiovip logo

Cardiovip

Covanos logo

Covanos

covanos.com

Carenostics logo

Carenostics

carenostics.com

Icardio.AI logo

Icardio.AI

icardio.ai

ThromboVision logo

ThromboVision

Cardio Diagnostics Holdings - Quick Facts

Who are Cardio Diagnostics Holdings' competitors?

Companies similar to Cardio Diagnostics Holdings include Cardiodiagnostics, HDL Diagnostics, Heartio and Arterial Health International.

When was Cardio Diagnostics Holdings founded?

Cardio Diagnostics Holdings was founded in 2017.

Where is Cardio Diagnostics Holdings' headquarters located?

Cardio Diagnostics Holdings' headquarters is located in Chicago, IL, US.

How many employees does Cardio Diagnostics Holdings have?

Cardio Diagnostics Holdings has 9 employees as of Feb 5, 2024.

Cardio Diagnostics Holdings - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Diagnostics
Tags
  • Biotech
  • Data Information
  • Healthcare
  • Healthtech
Unique IDs
  • ein: 870925574
  • secCik: 0001870144
  • ticker: CDIO
  • ticker: CDIOW
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2835In Vitro And In Vivo Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 18 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325413In-Vitro Diagnostic Substance Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 6700Holding And Other Investment Offices
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research